Generic placeholder image

Current Bionanotechnology (Discontinued)

Editor-in-Chief

ISSN (Print): 2213-5294
ISSN (Online): 2213-5308

Modulation of Innate Immune Responses Using Nanoparticles for Infectious Disease Therapy

Author(s): Admire Dube and Jessica L. Reynolds

Volume 2, Issue 1, 2016

Page: [60 - 65] Pages: 6

DOI: 10.2174/2213529402666160601120759

Price: $65

Abstract

Infectious diseases including HIV/AIDS and tuberculosis (TB) are a major cause of deaths worldwide. These intracellular pathogens regulate the innate immune response allowing for pathogen survival, persistence and further transmission. Nanoparticles provide an opportunity for the targeted delivery of immune modulating signals to host cells, harnessing the innate immune system to eradicate infection. In this review, we briefly present key aspects of HIV-1 and TB innate immunity, and review the capability of nanomedicines in modulating the action of the innate immune system. We conclude that while several studies have provided the proof of concept of the immunomodulatory ability of nanoparticle systems, additional characterization is required to facilitate the translation to the clinic of a nanomedicine approach to these diseases.

Keywords: HIV-1, TB, macrophage, targeted nanoparticle, immunotherapy, HIV-1 viral reservoir purging.

« Previous
Graphical Abstract

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy